Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy

Leukemia
V M PatelV Gandhi

Abstract

Acalabrutinib, a highly selective Bruton's tyrosine kinase inhibitor, is associated with high overall response rates and durable remission in previously treated chronic lymphocytic leukemia (CLL); however, complete remissions were limited. To elucidate on-target and pharmacodynamic effects of acalabrutinib, we evaluated several laboratory endpoints, including proteomic changes, chemokine modulation and impact on cell migration. Pharmacological profiling of samples from acalabrutinib-treated CLL patients was used to identify strategies for achieving deeper responses, and to identify additive/synergistic combination regimens. Peripheral blood samples from 21 patients with relapsed/refractory CLL in acalabrutinib phase I (100-400 mg/day) and II (100 mg BID) clinical trials were collected prior to and on days 8 and 28 after treatment initiation and evaluated for plasma chemokines, reverse phase protein array, immunoblotting and pseudoemperipolesis. The on-target pharmacodynamic profile of acalabrutinib in CLL lymphocytes was comparable to ibrutinib in measures of acalabrutinib-mediated changes in CCL3/CCL4 chemokine production, migration assays and changes in B-cell receptor signaling pathway proteins and other downstream survival ...Continue Reading

References

Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Feb 14, 2004·Blood·Freda K Stevenson, Federico Caligaris-Cappio
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Sep 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Amelia CimminoCarlo M Croce
Nov 20, 2009·Cell Cycle·Chong XuBarry M Gumbiner
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Lee A HonigbergJoseph J Buggy
Apr 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Shih-Shih ChenNicholas Chiorazzi
Mar 22, 2014·Blood·Holbrook E KohrtJohn C Byrd
Mar 25, 2014·Nature Reviews. Cancer·Rudi W HendriksLaurens P Kil
Apr 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sabine Ponader, Jan A Burger
Jun 3, 2014·The New England Journal of Medicine·John C ByrdUNKNOWN RESONATE Investigators
Sep 13, 2014·Journal of the National Cancer Institute·Wen GaoBingliang Fang
Dec 17, 2014·Neoplasia : an International Journal for Oncology Research·Kumudha BalakrishnanVarsha Gandhi
Apr 2, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fabiola Cervantes-GomezVarsha Gandhi
Jun 20, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarah E M HermanAdrian Wiestner
Dec 8, 2015·The New England Journal of Medicine·Jan A BurgerUNKNOWN RESONATE-2 Investigators
Dec 8, 2015·The New England Journal of Medicine·John C ByrdRichard R Furman
Dec 15, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carsten U NiemannAdrian Wiestner
Dec 31, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Viralkumar PatelVarsha Gandhi
Jun 25, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carsten U NiemannSarah E M Herman

❮ Previous
Next ❯

Citations

Jan 31, 2020·Expert Opinion on Emerging Drugs·Stefano MolicaLuciano Levato
May 15, 2020·Expert Opinion on Investigational Drugs·Elżbieta Iskierka-Jażdżewska, Tadeusz Robak
Jul 17, 2020·Frontiers in Oncology·Lenka SedlarikovaEva Kriegova
Mar 31, 2019·Targeted Oncology·Fabienne Lucas, Jennifer A Woyach
Jul 25, 2021·Cancers·Dimitra MavridouMichalis Aivaliotis
Dec 24, 2021·Blood·Elisa Ten Hacken, Catherine J Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Actin, Myosin & Cell Movement

Contractile forces generated by the actin-myosin cytoskeleton are critical for morphogenesis, but the cellular and molecular mechanisms of contraction have been elusive for many cell shape changes and movements. Here is the latest research on the roles of actin and myosin in cell movement.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.